Peripheral immunomodulation with ginsenoside Rg1 ameliorates neuroinflammation-induced behavioral deficits in rats.
Neuroscience
; 256: 210-22, 2014 Jan 03.
Article
in En
| MEDLINE
| ID: mdl-24161284
Key words
5-HIAA; 5-HT; 5-hydroxyindoleacetic acid; BBB; BDNF; CNS drug discovery; COX-2; EDTA; ELISA; HPA; ICAM-1; IL; Iba-1; KA; KYN; LCMS; LPS; MMPs; MPO; Mino; Myeloperoxidase; Rg1; TNF; bloodbrain barrier; brain-derived neurotrophin factor; cyclooxygenase-2; depression; enzyme-linked immunosorbent assay; ethylenediaminetetraacetic acid; ginsenoside Rg1; hypothalamicpituitaryadrenal; iNOS; inducible nitric oxide synthase; interleukin; intracellular adhesion molecule 1; ionized calcium-binding adaptor molecule-1; kynurenic acid; kynurenine; lipopolysaccharide; liquid chromatographymass spectrometry; matrix metalloproteinases; microglia; minocycline; neuroinflammation; peripheral target; qPCR; quantitative PCR; serotonin; tumor necrosis factor
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Plantas_medicinales
Main subject:
Central Nervous System Agents
/
Ginsenosides
/
Encephalitis
/
Mental Disorders
Type of study:
Diagnostic_studies
/
Prognostic_studies
Language:
En
Journal:
Neuroscience
Year:
2014
Type:
Article